Li, Mengdan <br/><br/>
Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.  [electronic resource] 

 -  Oncotarget  May 2017 
 - 36319-36330 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Biomarkers<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>DNA Mutational Analysis<br/>Disease Models, Animal<br/>Gallbladder Neoplasms--drug therapy<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Molecular Targeted Therapy<br/>Mutation<br/>NF-kappa B--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyridones--pharmacology<br/>Pyrimidinones--pharmacology<br/>Signal Transduction--drug effects<br/>Tumor Stem Cell Assay<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays